Indian markets and investors will assess the impact of IBM’s 23% plunge after weaker-than-expected preliminary quarterly results, with IT stocks including TCS, Infosys and Wipro set to remain in focus on Wednesday. Also, Wall Street’s overnight gains in the S&P…
Hero MotoCorp has approved an additional ₹1,000 crore investment in Ather Energy through a preferential share issue, strengthening its bet on the electric two-wheeler maker in which it already owns nearly 30%.
The proposed sale of 10.25 million shares to MetLife International Holdings will reduce the bank’s stake in the insurer to 2.534%. The transaction, approved by the board earlier, remains subject to documentation and regulatory formalities.
From Tata Elxsi and Anand Rathi reporting its Q1 results to Jain Resource Recycling reporting a furnace explosion at its manufacturing facility in Tamil Nadu, here are stocks to track ahead of Wednesday trading session.
FIIs remained net sellers for a second consecutive session, though the pace of outflows eased sharply. DIIs continued to provide support as markets declined amid geopolitical tensions and rising crude oil prices.
The lender told stock exchanges the government’s strategic disinvestment process is confidential and said it has not received any communication on the finalisation of the transaction.
Infosys and Wipro ADRs fell after IBM shares dropped 23% due to weak earnings. IBM’s revenue missed estimates, impacting software and infrastructure.
The five largest US banks generated nearly $50 billion in June-quarter profit, equal to almost half of the Nifty50’s entire FY26 earnings, highlighting the enormous earnings gap between Wall Street’s banking giants and India’s biggest listed companies.
America’s biggest lender reported $21.2 billion in quarterly profit, aided by one-off gains from divesting Visa shares, while Chief Executive Officer Jamie Dimon said the US economy remains resilient but warned of risks including inflation, geopolitical tensions and fiscal deficits.
Shares of IOL Chemicals and Pharmaceuticals Ltd ended at ₹174.55, up by ₹4.80, or 2.83%, on the BSE.